By Elsa Ohlen
Shares of pharmaceutical companies dropped early Monday after President Donald Trump said he would lower the cost of medicines for Americans by between 30% and 80%.
Shares of major U.S. drugmakers Eli Lilly, Pfizer, Merck, AbbVie and Amgen fell between 2% and 4% in premarket trading Monday.
The U.S. is the largest market for many global pharmaceutical companies, partly because of higher prices. Shares of European drugmakers like Novo Nordisk, Novartis and Roche also fell between 2% and 5% in morning trading.
Trump said he will institute a so-called "most-favored-nation" drug price policy, whereby the U.S. will pay the same price as the lowest price paid by comparable nations, in a post on social-media platform Truth Social late Sunday.
The price of prescription drugs can be as much as four times as high in the U.S. than in other wealthy nations, a Health Department-contracted study found in 2024.
The drop in pharma stocks comes as most of the market is rallying following a 90-day pause on the bulk of tariffs on trade between the U.S. and China, announced early Monday.
Write to Elsa Ohlen at elsa.ohlen@barrons.com
This content was created by Barron's, which is operated by Dow Jones & Co. Barron's is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
May 12, 2025 07:10 ET (11:10 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。